“Must-Read” review from BiotechIntel Novo Nordisk – the world’s largest insulin producer – and major diabetes drug manufacturers – could see BILLIONS in recurring revenue dry up as a small, California-based biotech company advances a technology that promises to change diabetes treatment. Over $100,000,000 has been invested in developing this super-drug that threatens to make […]
Our new investment opportunity with at least 100% ROI (return on investment) in short-term is Implant Sciences Corp. (IMSC) Implant Sciences develops and manufactures explosive trace detection sensors and systems that are capable of detecting minute amounts of a wide variety of military, commercial, and homemade explosives. IMSC’s patented technologies provide unique screening capabilities to […]
We love stocks for companies in healthcare sector, both in biotech and medical appliances industries, especially if these companies develop or already marketing their innovative products. Your investment here, particularly at early stages, not just helps increasing the companies’ financial flexibility for developing a new world-shattering drug and/or revolutionary medical device, but also offers the […]
Note: email to subscribers Brief research report on the undervalued investment opportunity: Sunshine Heart, Inc. (NASDAQ: SSH) 1. Company: Sunshine Heart focuses on an innovative cardiac assist therapy to treat heart patients who represent a large and under-served market segment. Company’s lead product, C-Pulse® Heart Assist System, is an innovative approach to assist the heart’s […]
Congratulations to the PennyStockHaven’s subscribers with gains of over 300% on the MRI Interventions, Inc. (MRIC). MRIC has been profiled at $1+ and topped $5 in a month time-frame. Be ready for the new investment opportunity pick to be delivered in your inbox this Sunday, July 8th, 2012:
A little bird told us about a little-known pinksheets company that could be the next big trade crowding every trader’s desk three weeks from now: TrovaGene, Inc. (TROV). So far TROV is available at a fraction of its true value. But not for long. Here’s why: TrovaGene is developing a patented technology for the detection […]
